Propionic Acid

Propionic Acid

SCHEMBL4162597

CCC(=O)O.COc1cc2[nH]c(=O)c3[nH]ccc3c2cc1OC

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 4/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRIN2D O15399 2/20 0.43
GRIN3B O60391 2/20 0.43
GRIN1 Q05586 2/20 0.43
GRIN2A Q12879 2/20 0.43
GRIN2B Q13224 2/20 0.43
GRIN2C Q14957 2/20 0.43
GRIN3A Q8TCU5 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
RET P07949 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4163220 0.91 KDM4E (0.37) KDM4EALDH1A1HPGDSMN1; SMN2GRIN2D
Propionic Acid SCHEMBL4153202 0.84 ACHE (0.47) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
Propionic Acid SCHEMBL4167721 0.81 PRKAG1 (0.46) KDM4EALDH1A1HPGDSMN1; SMN2POLB
Propionic Acid SCHEMBL4176382 0.79 GRIN1 (0.35) KDM4EALDH1A1HPGDSMN1; SMN2GRIN2D
Propionic Acid SCHEMBL4159540 0.79 PARP1 (0.43) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
Propionic Acid SCHEMBL4160624 0.79 MPO (0.43) KDM4ERETMAPK1
Propionic Acid SCHEMBL4165125 0.79 PARP1 (0.47) KDM4EALDH1A1HPGDSMN1; SMN2GRIN2D
Propionic Acid SCHEMBL4166119 0.79 PARP1 (0.49) KDM4EALDH1A1HPGDGRIN2DGRIN3B
Propionic Acid SCHEMBL4169911 0.79 GABRA1 (0.41) KDM4EALDH1A1HPGDGRIN2DGRIN3B
Propionic Acid SCHEMBL4155436 0.79 PIM3 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 KDM4E 1970/4885ALDH1A1 3830/4885HPGD 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.